about
Kinase suppressor of Ras 1 is required for full ERK activation in thymocytes but not for thymocyte selection.CD4+ T cell matters in tumor immunity.Role of NKG2D in obesity-induced adipose tissue inflammation and insulin resistance.Progress in the development of immunotherapy of cancer using ex vivo-generated dendritic cells expressing multiple tumor antigen epitopes.Generation of a stable plasmid for in vitro and in vivo studies of Staphylococcus.The balance between T cell receptor signaling and degradation at the center of the immunological synapse is determined by antigen quality.A dual function of NKG2D ligands in NK-cell activation.The p815 mastocytoma tumor model.Death of peripheral CD8+ T cells in the absence of MHC class I is Fas-dependent and not blocked by Bcl-xL.RAE1ε ligand expressed on pancreatic islets recruits NKG2D receptor-expressing cytotoxic T cells independent of T cell receptor recognition.New roles revealed for T cells and DCs in glomerulonephritis.NKG2D-NKG2D Ligand Interaction Inhibits the Outgrowth of Naturally Arising Low-Grade B Cell Lymphoma In VivoNKG2D Signaling between Human NK Cells Enhances TACE-Mediated TNF-α Release.More than Decoration: Roles for Natural Killer Group 2 Member D Ligand Expression by Immune Cells.A Protective Role for NKG2D-H60a Interaction via Homotypic T Cell Contact in Nonobese Diabetic Autoimmune Diabetes PathogenesisConstitutive expression of ULBP-4 on monocytes regulates NK cell NKG2D expressionContribution of YjbIH to Virulence Factor Expression and Host Colonization in Staphylococcus aureusInduction and Scoring of Graft-Versus-Host Disease in a Xenogeneic Murine Model and Quantification of Human T Cells in Mouse Tissues using Digital PCRProgesterone Receptor Attenuates STAT1-Mediated IFN Signaling in Breast CancerInterplay of Nitric Oxide Synthase (NOS) and SrrAB in Modulation of Staphylococcus aureus Metabolism and Virulence
P50
Q34293064-86FEFA8B-F4A6-4EF0-A17E-4755471544E1Q35214403-0E73B2EF-D1C5-47BF-B30E-D619FC36E12AQ35355536-740FCDBA-8A1F-43F5-B8E8-ABDBFD7AFB53Q35922431-B2C9DECF-9993-4C82-81B9-8AF7057DA056Q37405351-13A7E5DA-D8B8-4876-BB81-EF447A1433EEQ38411250-25844CFC-4A05-4320-8628-5288589C1803Q39323944-EA887131-3D40-4916-8A54-12EF3698DDC1Q39989077-B99E794F-0D54-45BF-A55C-D0FFE1411EC2Q40630623-7B784EE2-7F3D-4A1A-9780-A293A1A0C546Q40980436-936ECB7A-6614-43B8-A413-853DB3C166AFQ41790936-94A6ABA5-4ABE-4B3F-B86C-9B951C72EF0FQ42771120-487926DB-3C53-4E09-8734-90B24B016F91Q47820552-06134ECF-9E00-48C2-828F-2DD8347AC784Q55234629-DADCDBD9-A7F1-47A6-9393-165CD65805EFQ57257678-DFF8E018-EFEB-4AF6-81D1-4936B4DC0A37Q64290242-D6283A45-6850-4280-A28F-EC13DCFECECCQ92458663-7236C3C8-0523-48F5-A9AC-C4AAB3584F28Q92627535-2966A8FB-D779-414E-8DEE-59E68356EB89Q92766147-11E91F8D-170C-4445-8DF5-1971B903C434Q93015605-96170746-6AD1-4DE7-8DAD-D9641E85AFE3
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Mary A Markiewicz
@ast
Mary A Markiewicz
@en
Mary A Markiewicz
@es
Mary A Markiewicz
@nl
Mary A Markiewicz
@sl
type
label
Mary A Markiewicz
@ast
Mary A Markiewicz
@en
Mary A Markiewicz
@es
Mary A Markiewicz
@nl
Mary A Markiewicz
@sl
prefLabel
Mary A Markiewicz
@ast
Mary A Markiewicz
@en
Mary A Markiewicz
@es
Mary A Markiewicz
@nl
Mary A Markiewicz
@sl
P106
P21
P31
P496
0000-0001-5685-8573